Trials / Completed
CompletedNCT02678611
A Study to Evaluate Safety and Health Benefits of Basis™ Among Elderly Subjects.
A Randomized, Double-blind, Placebo Controlled Study to Evaluate Safety and Health Benefits of Basis™ Among Elderly Subjects.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Elysium Health · Industry
- Sex
- All
- Age
- 60 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This study will investigate the safety, tolerability and potential health benefits of the dietary supplement, Basis. There will be two doses of Basis compared to a placebo. One third of subjects will receive the low dose Basis, one third will receive the higher dose Basis and one third will receive placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Basis 250 | |
| DIETARY_SUPPLEMENT | Basis 500 | |
| DIETARY_SUPPLEMENT | Placebo |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-07-01
- First posted
- 2016-02-10
- Last updated
- 2016-08-01
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02678611. Inclusion in this directory is not an endorsement.